| Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 261.97M | 274.88M | 303.56M | 291.86M | 266.36M |
| Gross Profit | 116.57M | 121.12M | 115.46M | 113.50M | 111.64M |
| EBITDA | 62.93M | 63.63M | 58.88M | 59.16M | 58.12M |
| Net Income | 40.61M | 41.52M | 42.40M | 40.33M | 39.86M |
Balance Sheet | |||||
| Total Assets | 240.25M | 247.00M | 245.51M | 269.68M | 234.49M |
| Cash, Cash Equivalents and Short-Term Investments | 68.37M | 74.28M | 63.22M | 52.14M | 83.26M |
| Total Debt | 4.89M | 6.59M | 7.48M | 5.91M | 6.38M |
| Total Liabilities | 58.25M | 65.72M | 71.30M | 96.42M | 77.99M |
| Stockholders Equity | 182.00M | 181.28M | 174.21M | 173.26M | 156.49M |
Cash Flow | |||||
| Free Cash Flow | 34.38M | 46.02M | 46.84M | 3.31M | 53.10M |
| Operating Cash Flow | 38.26M | 49.33M | 49.70M | 6.56M | 55.91M |
| Investing Cash Flow | -1.17M | -563.00K | -2.72M | -2.97M | -2.68M |
| Financing Cash Flow | -40.17M | -37.59M | -35.52M | -34.85M | -37.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £1.30B | 12.17 | -2.81% | 2.12% | -4.34% | -220.12% | |
74 Outperform | £282.44M | 117.95 | 6.14% | 3.48% | -3.93% | 41.83% | |
70 Neutral | £109.88M | 13.87 | 7.28% | 3.97% | 5.51% | -33.75% | |
70 Neutral | £501.45M | 16.44 | 22.71% | 5.91% | -4.70% | -2.21% | |
66 Neutral | £88.72M | 7.45 | 18.04% | 4.63% | 12.60% | 6.64% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £734.34M | 18.00 | 7.59% | 3.19% | 5.88% | 107.36% |
James Halstead plc has disclosed a series of transactions involving non-executive director Michael James Halstead and his closely associated persons, in line with Market Abuse Regulation reporting requirements. On 20 February 2026, a total of 52,000 ordinary shares were transferred from Halstead’s nominee account, with 19,250 shares moving into his personal ISA and additional tranches allocated to ISA accounts for Maria and Katherine Claire Halstead.
These dealings, all priced at £1.36 per share and executed on AIM, represent a reorganisation of existing holdings rather than a change in overall economic exposure to the company. The moves underscore continued insider alignment with the business while signalling routine personal tax and investment planning, with limited immediate implications for the company’s operations or broader shareholder base.
The most recent analyst rating on (GB:JHD) stock is a Hold with a £148.00 price target. To see the full list of analyst forecasts on James Halstead stock, see the GB:JHD Stock Forecast page.
James Halstead plc has bought back 375,000 of its 5p ordinary shares at a corrected weighted price of 136.89 pence per share and will cancel the repurchased stock rather than holding it in treasury. Following settlement and cancellation, the total number of ordinary shares in issue will fall to 416,411,436, setting the new base for shareholder voting rights and regulatory disclosure thresholds under the FCA’s rules.
The most recent analyst rating on (GB:JHD) stock is a Hold with a £146.00 price target. To see the full list of analyst forecasts on James Halstead stock, see the GB:JHD Stock Forecast page.
James Halstead plc has bought back 375,000 of its ordinary 5p shares at a weighted price of 1.3689 pence per share and will cancel them rather than hold them in treasury. Following settlement and cancellation, the company’s share capital will comprise 416,411,436 ordinary shares in issue, with no shares held in treasury, thereby slightly reducing the number of voting shares in the market and adjusting the base for shareholders’ disclosure calculations under FCA transparency rules.
The most recent analyst rating on (GB:JHD) stock is a Hold with a £146.00 price target. To see the full list of analyst forecasts on James Halstead stock, see the GB:JHD Stock Forecast page.
James Halstead has reported that sales for the half year to 31 December 2025 will show a slight decline versus the prior year, with challenging conditions in Central Europe and Asia Pacific weighing on overall revenue, though UK sales remain marginally ahead and trading in North America, the Middle East and South Africa continues to grow. A conservative approach to customer credit has dampened revenue and will result in a modest reduction in profitability for the period, but the board highlights rising cash balances, an ungeared balance sheet and ongoing investment in UK sites, alongside new and updated product ranges and management changes in APAC, as drivers expected to support improved revenue and profitability in the second half.
The most recent analyst rating on (GB:JHD) stock is a Hold with a £148.00 price target. To see the full list of analyst forecasts on James Halstead stock, see the GB:JHD Stock Forecast page.